The IRA is already curtailing small molecule drug development. Here’s how to reverse that—GLP-1s like Novo Nordisk’s Ozempic do not increase thyroid cancer risk—Bayer, Google partner on AI for time-pressed radiologists--http://bit.ly/w28kSd #IRA #innovation #inflationreductionact #glp1 #novonordisk #ozempic #thyroidcancer #artificialintelligence #google #bayer #radiologists #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma